Barry G. Garchow

557 citations
9 papers · 429 indexed · h-index 8
Topics
MicroRNA in disease regulation (6 papers)Phytase and its Applications (2 papers)RNA Interference and Gene Delivery (2 papers)
Partner nations
United StatesDenmark

In The Last Decade

Barry G. Garchow

9 papers receiving 426 citations

Peers

Barry G. Garchow
Comparison fields: 5 of 60
  • Molecular Biology 321
  • Cancer Research 242
  • Immunology 74
  • Rheumatology 49
  • Plant Science 45
Replace Lijuan Zhu with:
Lijuan Zhu China
Gabriel Adelman Cipolla Brazil
Sebastiano Di Bella Italy
Roshan Vaid Sweden
Julien Jarroux United States
Tongyu Sun United States
Wan‐Ting Kan Australia
Giorgia Montano Sweden
Barry G. Garchow relative to Lijuan Zhu China Lijuan Zhu's profile →
Citations per field
00.5×11.3×
Lijuan Zhu · 1×
Citations per year

Countries citing papers authored by Barry G. Garchow

Since Specialization
Citations

This map shows the geographic impact of Barry G. Garchow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry G. Garchow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry G. Garchow more than expected).

Fields of papers citing papers by Barry G. Garchow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry G. Garchow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry G. Garchow. The network helps show where Barry G. Garchow may publish in the future.

Co-authorship network of co-authors of Barry G. Garchow

This figure shows the co-authorship network connecting the top 25 collaborators of Barry G. Garchow. A scholar is included among the top collaborators of Barry G. Garchow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry G. Garchow. Barry G. Garchow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 22
2
Two interesting cases of intracranial IgG4-related disease and discussion of therapy options.
2
3 32
4 147
5 16
6 73
7 102
8 13
9 22

About Barry G. Garchow

Barry G. Garchow is a scholar working on Cancer Research, Rheumatology and Immunology, having authored 9 papers that have together received 429 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Phytase and its Applications (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Cancer Research (242 citations), Molecular Biology (321 citations) and Immunology (74 citations). Barry G. Garchow has collaborated with scholars based in United States and Denmark. Frequent co-authors include Marianthi Kiriakidou, Grace Tan, Xuhang Liu, Andreas Petri, Óscar Bártulos, David E. Metzler, Patricia Tsao, Roberto Caricchio, Sakari Kauppinen and Susanna Obad. Their work appears in journals such as Nucleic Acids Research, Archives of Biochemistry and Biophysics and Molecular Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026